EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma

Di Wang iD, Wei Zhang iD, Xudong Gao, Huifang Kong iD, Huixin Zhang, Jiagan Huang iD, Meng Zhang, Xiujuan Chang, Zhen Zeng

Cancer Management and Research · 2026-04 · Volume 18 · 1-19

DOI: 10.2147/cmar.s578610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Management and Research, 2026-04. Verfasst von Di Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: 302 Clinical Medical School, Peking University, Beijing, People's Republic of China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

PD-1 inhibitorregorafenibsecond-line therapytransarterial chemoembolizationunresectable hepatocellular carcinoma

Autor:innen und Institutionen

  • 302 Clinical Medical School, Peking University, Beijing, People's Republic of China.
  • Senior Department of Liver Disease Medicine, Chinese PLA General Hospital, Beijing, People's Republic of China.

ORCID-Profile: Di Wang, Wei Zhang, Huifang Kong, Jiagan Huang

Zitieren

APA

Wang, D., Zhang, W., Gao, X., Kong, H., Zhang, H., Huang, J., Zhang, M., Chang, X., & Zeng, Z. (2026). Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma. Cancer Management and Research, Volume 18, 1-19. https://doi.org/10.2147/cmar.s578610

Vancouver

Wang D, Zhang W, Gao X, Kong H, Zhang H, Huang J, et al. Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma. Cancer Management and Research. 2026;Volume 18:1-19. doi:10.2147/cmar.s578610

BibTeX
@article{Wang2026,
  author = {Wang, Di and Zhang, Wei and Gao, Xudong and Kong, Huifang and Zhang, Huixin and Huang, Jiagan and Zhang, Meng and Chang, Xiujuan and Zeng, Zhen},
  title = {Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma},
  journal = {Cancer Management and Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--19},
  doi = {10.2147/cmar.s578610}
}
Kostenlos starten →